SYRE Spyre Therapeutics reports narrower Q4 2025 pershare loss than consensus forecasts with shares edging higher in todays trading SLNO Soleno Therapeutics tops Q4 2025 EPS estimates by 103 percent shares edge 021 percent lower today Aldabra 4 ALOV Stock Is It Trending Up ALOV Latest Quarter Earnings Aldabra 4 reports no operating results amid SPAC merger pursuit